The FDA has launched an investigating into the possibility that diabetics may face an increased risk of pancreatitis and pancreatic cancer from an entire class of diabetes drugs, which includes…
A new study involving Americans with type 2 diabetes suggests that those who take the drugs Byetta and Januvia may face an increased risk of being hospitalized with acute pancreatitis,…
As many as 20% of doctors may shy away from prescribing Byetta or Januvia due to a possible increased risk of pancreatitis and pancreatic cancer, according to new research.
The findings of new research suggest that the popular diabetes drugs Byetta and Januvia could increase the risk of pancreatitis and pancreatic cancer.
Diabetes experts meeting in Lisbon this week are taking a close look at whether a class of long-acting diabetes drugs, including Byetta and Victoza, could be linked to an increased…
Federal regulators have signed off on a redesign for the labels of a number of Merck drugs, including Zocor, Propecia, Januvia and a dozen other drugs, to improve readability and…
The consumer watchdog group Public Citizen is raising questions about the effectiveness and possible side effects of Onglyza, a relatively new diabetes drug.
A new study by U.S. researchers appears to cast doubt on claims that the side effects of Byetta and Januvia, two drugs used to treat diabetes, increase the risk of acute…
Following an FDA alert issued Friday about reports of acute pancreatitis associated with use of Januvia and Janumet, Merck & Co., the maker of both diabetes drugs, issued a statement…
The FDA indicated today that the prescribing information for the diabetes drugs Januvia (sitagliptin) and Janumet (sitagliptin/metformin) will be updated to provide additional information about potential pancreatitis side effects, including…
